Celularity Financial Statements From 2010 to 2025
| CELU Stock | USD 3.19 0.10 3.04% |
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as , as well as many indicators such as . Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
Celularity | Build AI portfolio with Celularity Stock |
Celularity Company Operating Margin Analysis
Celularity's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Celularity Operating Margin | (0.52) % |
Most of Celularity's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celularity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Celularity has an Operating Margin of -0.5225%. This is 98.51% lower than that of the Biotechnology sector and 99.53% lower than that of the Health Care industry. The operating margin for all United States stocks is 90.52% lower than that of the firm.
Celularity Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Celularity's current stock value. Our valuation model uses many indicators to compare Celularity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celularity competition to find correlations between indicators driving Celularity's intrinsic value. More Info.Celularity is rated fourth in return on equity category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Celularity by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Celularity Financial Statements
Celularity shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey. Celularity operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.